| Announce Date | 10/30/2025 | 
| EPS Normalized Actual | $0.67 (Beat by $0.074) | 
| EPS GAAP Actual | $0.67 (Beat by $0.074) | 
| Revenue Actual | $1.5531B | 
| Revenue Surprise | Beat by $1553.1M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.77311 | 
| EPS GAAP Estimate | $0.77311 | 
| Revenue Estimate | $1.770126335B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 4.026 | 20.62 | 3.93182 | 4.47721 | 1 | 
| Dec 2028 | 4.314 | 19.25 | 4.21065 | 4.43924 | 3 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.5 | -0.28315 | 1.5531B | 12.79% | -248.65M | 
| FQ2 2025 (Jun 2025) | 0.57 | -0.21427 | 1.5322B | 9.55% | -275.39M | 
| FQ1 2025 (Mar 2025) | 0.61 | 0.61 | 1.4127B | -13.13% | 1412.7M | 
| FQ4 2024 (Dec 2024) | 0.65 | 0.65 | 1.3858B | -10.7% | 1385.8M | 
| FQ3 2024 (Sep 2024) | 5.14 | 5.14 | 1.3544B | -9.34% | 1354.4M | 
| FQ2 2024 (Jun 2024) | 0.61 | 0.61 | 1.3859B | -10.41% | 1385.9M | 
| FQ1 2024 (Mar 2024) | 0.58 | 0.58 | 1.5982B | 8.67% | 1598.2M | 
| FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 1.5341B | 12.11% | 1534.1M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.77311
Consensus Revenue Estimates
1.770126335B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.8014 | -- | 0.7842 | 0.82275 | 12 | 
| FQ3 2027 (Sep 2027) | 0.76763 | -- | 0.75116 | 0.78808 | 7 | 
| FQ2 2027 (Jun 2027) | 0.75923 | -- | 0.74294 | 0.77946 | 7 | 
| FQ1 2027 (Mar 2027) | 0.72059 | -- | 0.70513 | 0.73979 | 8 | 
| FQ4 2026 (Oct 2026) | 0.87686 | -- | 0.85129 | 0.90336 | 7 | 
| FQ3 2026 (Jul 2026) | 0.87751 | 43.02 | 0.85192 | 0.90403 | 12 | 
| FQ2 2026 (Jun 2026) | 0.87982 | 35.21 | 0.85491 | 0.90552 | 12 | 
| FQ1 2026 (Mar 2026) | 0.83147 | 26.64 | 0.80793 | 0.85576 | 7 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.83B | -- | 1.8B | 1.87B | 13 | 
| FQ3 2027 (Sep 2027) | 1.78B | -- | 1.75B | 1.82B | 8 | 
| FQ2 2027 (Jun 2027) | 1.76B | -- | 1.73B | 1.79B | 8 | 
| FQ1 2027 (Mar 2027) | 1.67B | -- | 1.64B | 1.7B | 9 | 
| FQ4 2026 (Oct 2026) | 1.97B | -- | 1.92B | 2.01B | 8 | 
| FQ3 2026 (Jul 2026) | 1.99B | 22.08 | 1.95B | 2.04B | 13 | 
| FQ2 2026 (Jun 2026) | 2B | 23.36 | 1.96B | 2.04B | 13 | 
| FQ1 2026 (Mar 2026) | 1.9B | 25.71 | 1.86B | 1.94B | 8 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.78315 | 0.5 | -0.28315 | -56.63% | 
| FQ2 2025 (Jun 2025) | 0.78427 | 0.57 | -0.21427 | -37.59% | 
| FQ1 2025 (Mar 2025) | 0.61 | 0.61 | 100% | |
| FQ4 2024 (Dec 2024) | 0.65 | 0.65 | 100% | |
| FQ3 2024 (Sep 2024) | 5.14 | 5.14 | 100% | |
| FQ2 2024 (Jun 2024) | 0.61 | 0.61 | 100% | |
| FQ1 2024 (Mar 2024) | 0.58 | 0.58 | 100% | |
| FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.8B | $1.55B | $-248.65M | -16.01% | 
| FQ2 2025 (Jun 2025) | $1.81B | $1.53B | $-275.39M | -17.97% | 
| FQ1 2025 (Mar 2025) | $0B | $1.41B | $1412.7M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $1.39B | $1385.8M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $1.35B | $1354.4M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $1.39B | $1385.9M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $1.6B | $1598.2M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $1.53B | $1534.1M | 100% |